---
format:
  revealjs:
    width: 1920
    height: 1080
    transition: fade
    theme: style.scss
    fontsize: "60px"
    slide-number: true
fontcolor: white
---
## {background-image="images/first-slide.png"}

## Prediction {background-image="images/background.png"}
\
\
\
***How much time will it take me to drive to work?***


## Prediction of healthcare outcomes {background-image="images/background.png"}
\
\

> **Question:**
>
> *For a specific patient, how likely is it that they experience an outcome of
> interest?*

\


:::{.fragment}

How likely is it for a patient with:

- osteoporosis to experience a vertebral fracture?
- COVID-19 to be transferred to the ICU ?

:::

## Prediction of benefit {background-image="images/background.png"}
\
\

> **Question:**
>
> *For a specific patient, between treatment A and treatment B, which one is
> better?*

## Prediction of benefit {background-image="images/background.png"}
\
\

> **Problem:**
>
> *We can never observe what would have happened, had the patient received the
> alternative treatment.*


## Prediction of benefit {background-image="images/background.png"}
\
\
Thought process:
\
\


[*Time machine*]{.fragment} [❯ *Cloning*]{.fragment} [❯ *Twin siblings*]{.fragment} [❯ *Similar patients*]{.fragment}



## Prediction of benefit {background-image="images/background.png"}
\
\

> **Question:**
>
> *What makes two patients similar?*

## Literature review {background-image="images/background.png"}
\
\

> **Aim 1:**
>
> *Systematically review the current literature on predictive approaches to
> treatment effect heterogeneity.*


## Literature review {background-image="images/background.png"}
\
\

***Treatment effect modeling methods:*** 
\
Similiarity is based on risk factors and effect
modfiers.

\

***Risk-based methods:***
\
Similarity is based solely on risk factors.

\

***Optimal treatment regimes:***
\
Similarity is based solely on effect modifiers.



## Risk-based methods {background-image="images/background.png"}
\
\

> **Aim 2:**
>
> *Develop scalable and reproducible risk-based predictive approaches to the
> assessment of treatment effect heterogeneity.*

## Observational setting {background-image="images/background.png"}
\
\

> **Problem:**
> 
> *Patients receiving different treatments tend to be systematically different.*

\
\

## Observational setting {background-image="images/background.png"}
\
\

> **Problem:**
>
> *Lack of syntactic and semantic interoperability between observational
> databases.*

## Standardized framework {background-image="images/background.png"}
\
\

::::{.columns}

:::{.column width="50%"}
![](images/framework.png){fig-align="center"}
:::
:::{.column width="50%"}
![](images/framework-main.png){.absolute top=150 right=0 width="45%"}
![](images/osteoporosis.png){.absolute bottom=-20 right=0 width="45%"}
:::
::::

## Continuous benefit prediction {background-image="images/background.png"}
\
\

## Prediction in healthcare {background-image="images/background.png"}

![](images/cope.png){.absolute width="70%" left=0}

![](images/nomogram.png){.absolute width="60%" right=0 bottom=0}

